Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Cerus Corp Stock Research

CERS

1.50USD-0.01(-0.66%)Delayed
Watchlist

Market Summary

USD1.50-0.01
Delayed
-0.66%

CERS Alerts

  • 2 major insider buys recently.

CERS Stock Price

CERS RSI Chart

CERS Valuation

Market Cap

270.9M

Price/Earnings (Trailing)

-5.31

Price/Sales (Trailing)

2.62

EV/EBITDA

-6.09

Price/Free Cashflow

-10.8

CERS Price/Sales (Trailing)

CERS Profitability

EBT Margin

-24.26%

Return on Equity

-78.66%

Return on Assets

-22.03%

Free Cashflow Yield

-9.26%

CERS Fundamentals

CERS Revenue

Revenue (TTM)

188.3M

Revenue Y/Y

-58.16%

Revenue Q/Q

-58.16%

CERS Earnings

Earnings (TTM)

-51.0M

Earnings Y/Y

-58.24%

Earnings Q/Q

15.13%

Price Action

52 Week Range

1.474.25
(Low)(High)

Last 7 days

-8.0%

Last 30 days

-14.3%

Last 90 days

-37.5%

Trailing 12 Months

-58.1%

CERS Financial Health

Current Ratio

2.09

CERS Investor Care

Shares Dilution (1Y)

2.07%

Diluted EPS (TTM)

-0.28

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for CERS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-08-22
Lucena Ann
bought
12,637
1.685
7,500
-
2023-08-21
BJERKHOLT ERIC
bought
17,151
1.7151
10,000
-
2023-06-07
MOORE TIMOTHY L.
acquired
200,000
5.00
40,000
-
2023-06-07
Lucena Ann
acquired
200,000
5.00
40,000
-
2023-06-07
NACHTSHEIM JAMI K
acquired
200,000
5.00
40,000
-
2023-06-07
SCHULZE GAIL
acquired
200,000
5.00
40,000
-
2023-06-07
Swisher Daniel N JR
acquired
200,000
5.00
40,000
-
2023-06-07
BJERKHOLT ERIC
acquired
200,000
5.00
40,000
-
2023-06-07
Witney Frank
acquired
200,000
5.00
40,000
-
2023-05-26
Swisher Daniel N JR
bought
9,535
1.907
5,000
-

1–10 of 50

Which funds bought or sold CERS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-20
BARCLAYS PLC
added
80.72
968,000
2,917,000
-%
2023-09-01
Portside Wealth Group, LLC
new
-
69,501
69,501
0.01%
2023-08-23
WOLVERINE TRADING, LLC
reduced
-82.2
-169,983
31,017
-%
2023-08-22
VIRGINIA RETIREMENT SYSTEMS ET AL
sold off
-100
-175,527
-
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-2.16
-123,920
529,554
-%
2023-08-21
OSAIC HOLDINGS, INC.
added
16.00
-1,247
26,898
-%
2023-08-16
CreativeOne Wealth, LLC
sold off
-100
-72,000
-
-%
2023-08-16
Nuveen Asset Management, LLC
added
8.92
-353,919
3,265,080
-%
2023-08-15
ALLIANCEBERNSTEIN L.P.
unchanged
-
-103,094
497,274
-%
2023-08-15
GOLDMAN SACHS GROUP INC
reduced
-37.9
-893,472
946,301
-%

1–10 of 47

Latest Funds Activity

Are funds buying CERS calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CERS
No. of Funds

Schedule 13G FIlings of Cerus

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
baker bros. advisors lp
9.1%
16,067,558
SC 13G/A
Feb 10, 2023
nikko asset management americas, inc.
4.04%
7,171,280
SC 13G/A
Feb 10, 2023
ark investment management llc
10.11%
17,943,131
SC 13G/A
Feb 10, 2023
ark investment management llc
8.94%
15,863,384
SC 13G/A
Feb 09, 2023
vanguard group inc
6.14%
10,900,422
SC 13G/A
Feb 03, 2023
sumitomo mitsui trust holdings, inc.
4.04%
7,171,280
SC 13G/A
Jan 31, 2023
blackrock inc.
7.1%
12,594,054
SC 13G/A
Jan 09, 2023
primecap management co/ca/
4.99%
8,849,600
SC 13G/A
Feb 14, 2022
nikko asset management americas, inc.
6.69%
11,529,716
SC 13G/A
Feb 10, 2022
primecap management co/ca/
5.64%
9,722,300
SC 13G/A

Recent SEC filings of Cerus

View All Filings
Date Filed Form Type Document
Aug 23, 2023
4
Insider Trading
Aug 23, 2023
4
Insider Trading
Aug 03, 2023
10-Q
Quarterly Report
Aug 02, 2023
8-K
Current Report

Peers (Alternatives to Cerus)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
108.3B
19.5B
3.38% 36.58%
39.99
5.57
10.36% 30.30%
101.2B
6.7B
-0.75% 50.83%
71.05
15.19
11.75% -0.66%
77.5B
13.4B
6.45% 36.39%
85
5.78
8.69% 3.17%
71.3B
19.0B
-4.29% 12.66%
44.09
3.79
0.46% -5.24%
42.3B
5.7B
-8.22% -17.24%
30.48
7.49
5.64% -4.53%
MID-CAP
9.5B
937.8M
-2.12% 37.22%
325.65
10.11
16.30% 250.21%
7.1B
616.6M
-12.54% -24.86%
29.24
11.56
69.52% 343.68%
5.1B
1.1B
-6.10% -12.07%
24.23
4.65
12.63% 50.85%
2.6B
452.1M
-21.20% -33.94%
-26.32
5.78
24.99% 24.09%
1.3B
790.3M
-27.09% -56.49%
-5.97
1.69
3.21% -1604.53%
SMALL-CAP
1.6B
421.8M
-15.15% 56.11%
-9.32
3.69
44.49% -2.43%
947.4M
780.7M
-7.75% -9.65%
-26.32
1.21
4.68% -510.17%
839.3M
239.8M
0.70% 0.15%
-22.16
3.5
-4.74% -31.15%
609.7M
162.9M
-27.67% -61.65%
-11.53
3.74
42.67% 12.82%

Cerus News

MarketBeat
Cerus Co. (NASDAQ:CERS) Shares Sold by ARK Investment ....
MarketBeat,
7 days ago
Defense World
InvestorsObserver
Investor's Business Daily
8 Big Stock Disasters Knock Cathie Wood Off Her Perch.
Investor's Business Daily,
37 days ago
Investor's Business Daily
Investors Who Bet Against Cathie Wood Pay The Price.
Investor's Business Daily,
2 months ago

Returns for CERS

Cumulative Returns on CERS

-12.7%


10-Year Cumulative Returns

-18.4%


7-Year Cumulative Returns

-27.3%


5-Year Cumulative Returns

-37.8%


3-Year Cumulative Returns

Risks for CERS

What is the probability of a big loss on CERS?

100%


Probability that Cerus stock will be more than 20% underwater in next one year

93.5%


Probability that Cerus stock will be more than 30% underwater in next one year.

58.1%


Probability that Cerus stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CERS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Cerus was unfortunately bought at previous high price.

Drawdowns

Financials for Cerus

Income Statement (Last 12 Months)
Income Statement (Last 12 Months)
Description(%) Q/Q2022Q42021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q12017Q42017Q32017Q22017Q1
Revenue18.1%188,315,000159,518,000126,500,000120,605,000116,242,000114,249,00098,911,00096,693,00094,993,00093,774,00084,466,00081,287,00078,889,00076,051,00037,431,00040,971,00042,796,00043,568,00037,453,00036,831,00036,557,000
Gross Profit-------------------18,446,00017,721,00016,831,000
Operating Expenses1.7%147,442,000144,979,000143,156,000139,731,000134,620,000131,425,000129,275,000129,276,000128,703,000126,581,000120,233,000112,801,000105,962,00099,405,00092,491,00087,818,00086,536,00086,325,00087,440,000--
  S&GA Expenses2.5%83,335,00081,288,00077,976,00073,918,00070,272,00067,015,00065,488,00065,329,00065,957,00066,205,00063,874,00061,698,00059,395,00056,841,00054,565,00052,831,00052,539,00052,615,00052,699,000--
EBITDA28.1%-33,522,000-46,634,000-52,517,000-54,528,000-54,452,000-53,627,000-55,654,000-59,530,000-62,052,000-62,716,000-----------
EBITDA Margin39.1%-0.18-0.29-0.42-0.45-0.47-0.47-0.56-0.62-0.65-0.67-----------
Interest Expenses18.4%5,831,0004,923,0004,541,0004,192,0003,783,0003,746,0003,754,0003,855,0004,076,0006,065,0006,187,0006,209,0006,017,0004,008,0003,826,0003,863,0003,406,0003,022,0002,668,000--
Earnings Before Taxes21.7%-42,337,000-54,057,000-59,296,000-61,003,000-60,523,000-59,573,000-62,125,000-65,961,000-68,658,000-70,981,000-70,285,000-66,514,000-62,236,000-57,335,000-52,750,000-51,982,000-51,966,000-56,698,000-59,843,000--
EBT Margin33.7%-0.22-0.34-0.47-0.51-0.52-0.52-0.63-0.68-0.72-0.76-----------
Net Income21.3%-42,779,000-54,374,000-59,636,000-61,338,000-60,848,000-59,857,000-62,399,000-66,227,000-68,918,000-71,244,000-70,526,000-66,751,000-62,471,000-57,564,000-52,845,000-52,071,000-55,872,000-60,585,000-62,600,000--
Net Income Margin33.4%-0.23-0.34-0.47-0.51-0.52-0.52-0.63-0.68-0.73-0.76-----------
Free Cashflow20.7%-27,615,000-34,832,000-42,513,000-41,141,000-41,341,000-43,426,000-42,131,000-61,486,000-69,195,000-74,434,000-----------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets-5.0%199209218215216222237219223221221213215215166164175176163162152
  Current Assets-7.0%151162170165165173187178186181183177179178128126136135147150141
    Cash Equivalents-25.2%21.0028.0036.0029.0034.0040.0051.0081.0061.0060.0039.0031.0037.0036.0037.0027.0026.0032.0032.0025.0017.00
  Inventory10.9%41.0037.0029.0028.0028.0029.0027.0029.0031.0024.0023.0019.0018.0022.0019.0021.0017.0016.0014.0013.0013.00
  Net PPE-5.3%10.0011.0011.0011.0011.0012.0012.0013.0013.0013.0014.0014.0015.0015.0015.0015.0015.0016.008.003.002.00
  Goodwill0%1.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.001.00
Liabilities-1.7%14715015014114014115213813912811810410110310810410910679.0070.0061.00
  Current Liabilities-3.2%75.0078.0011795.0079.0067.0079.0065.0066.0055.0060.0046.0043.0045.0050.0046.0051.0048.0053.0043.0028.00
Shareholder's Equity-14.7%51.0060.0068.0073.0077.0080.0086.0081.0084.0093.0010410911511257.0061.0066.0070.0085.0092.0090.00
  Retained Earnings-1.3%-1,036-1,022-1,007-993-985-976-964-955-942-927-909-895-881-866-850-833-815-797-778-762-748
  Additional Paid-In Capital0.5%1,0891,0831,0771,0701,0631,0571,0491,0351,0271,0191,0131,004995979907894881867864855839
Shares Outstanding1.3%181178178177177174174172171169168167164157140141138137132130128
Minority Interest-6.0%1.001.001.001.001.001.001.001.00-------------
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Last 12 Months)
(In Thousands)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations-68.3%-21,310-12,659-25,615-25,081-29,605-37,923-33,922-41,601-40,208-39,464-41,811-41,132-58,160-63,123-65,499-64,372-47,051-43,099-31,246-34,186-42,143
  Share Based Compensation3.0%24,41223,69924,45623,73923,86324,66423,57121,75620,71019,60818,02917,00615,75514,18813,31212,42711,50310,95710,3949,9269,646
Cashflow From Investing432.6%6,000-1,8048,464-39,209-15,414-82.0012,68860,58033,47122,019-49,558-47,759-32,351-35,18528,18526,01116,51314,080-43,848-55,683-68,547
Cashflow From Financing-9.9%3,4293,8044,19215,83319,33019,25534,29430,48330,07340,58791,78392,980101,875103,03843,48740,40239,72443,05792,75197,684107,198

CERS Income Statement

2023-06-30
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:    
Research and development$ 19,184$ 15,216$ 36,568$ 29,273
Selling, general and administrative20,54119,53242,09240,267
Restructuring2,128 2,128 
Total operating expenses41,85334,74880,78869,540
Loss from operations(11,640)(6,835)(25,786)(16,683)
Non-operating expense, net:    
Foreign exchange gain (loss)49(104)(144)(302)
Interest expense(2,181)(1,348)(3,793)(2,728)
Other income (expense), net539(30)926(812)
Total non-operating expense, net(1,593)(1,482)(3,011)(3,842)
Loss before income taxes(13,233)(8,317)(28,797)(20,525)
Provision for income taxes9878175154
Net loss(13,331)(8,395)(28,972)(20,679)
Net loss attributable to noncontrolling interest(56)(6)(78)(6)
Net loss attributable to Cerus Corporation$ (13,275)$ (8,389)$ (28,894)$ (20,673)
Net loss per share attributable to Cerus Corporation    
Basic$ (0.07)$ (0.05)$ (0.16)$ (0.12)
Diluted$ (0.07)$ (0.05)$ (0.16)$ (0.12)
Weighted average shares outstanding:    
Basic180,611176,944179,449175,718
Diluted180,611176,944179,449175,718
Product    
Revenue$ 38,853$ 40,999$ 69,827$ 78,443
Cost of revenue17,51519,71831,20237,794
Gross profit21,33821,28138,62540,649
Government Contract    
Revenue$ 8,875$ 6,632$ 16,377$ 12,208

CERS Balance Sheet

2023-06-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 20,635$ 35,585
Short-term investments63,86866,569
Accounts receivable22,17534,426
Current inventories40,60829,003
Prepaid and other current assets3,6504,561
Total current assets150,936170,144
Non-current assets:  
Property and equipment, net10,25410,969
Operating lease right-of-use assets12,26812,512
Goodwill1,3161,316
Restricted cash1,7931,773
Other assets22,29321,378
Total assets198,860218,092
Current liabilities:  
Accounts payable37,48933,002
Accrued liabilities17,51025,203
Debt – current16,54256,159
Operating lease liabilities – current2,1762,105
Deferred product revenue1,361589
Total current liabilities75,078117,058
Non-current liabilities:  
Debt – non-current54,83813,644
Operating lease liabilities – non-current14,45415,329
Other non-current liabilities2,8003,499
Total liabilities147,170149,530
Commitments and contingencies
Stockholders' equity:  
Common stock181177
Additional paid-in capital1,089,0831,077,341
Accumulated other comprehensive loss(2,433)(2,787)
Accumulated deficit(1,036,015)(1,007,121)
Total Cerus Corporation stockholders' equity50,81667,610
Noncontrolling interest874952
Total liabilities and stockholders' equity$ 198,860$ 218,092
William M. Greenman
290
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.